Drug Database
Back to search

United States· US:47335-956_70258299-7c72-4a10-8d0c-4a5e3b2a0fc8

Alfuzosin Hydrochloride

A alfuzosin product containing alfuzosin hydrochloride, registered in United States by Sun Pharmaceutical Industries, Inc.. The same ATC class is registered in 18 of our 19 countries.

ATC G04CA01US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedAlfuzosin HydrochlorideATCG04CA01REGISTER NO.US:47335-956_70258299…PACKS LISTED10CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about alfuzosin hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Alfuzosin is registered in 18 of 19 countries.

Countries holding a registration under ATC G04CA01 (alfuzosin), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 11 of them publish a price we can compare per daily dose
Search alfuzosin products by name

Alfuzosin · ATC G04CA01

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of alfuzosin costs, country by country.

Normalised to the WHO defined daily dose (7.5 mg), the median price runs from $0.25 in France to $0.93 in Switzerland — a ×3.7 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Alfuzosin · price per daily dose (7.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.93
  • ES Spain$0.34
  • IT Italy$0.25
  • FR France$0.25
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
ALFUZOSIN HYDROCHLORIDE
Manufacturer
Sun Pharmaceutical Industries, Inc.
Country
United States (US)
ATC code
G04CA01
ATC class
Alfuzosin
Defined daily dose
7.5 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 10

  • ndc11
    4733595608
    100 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-956-08)
  • ndc11
    4733595618
    1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-956-18)
  • ndc11
    4733595681
    90 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-956-81)
  • ndc11
    4733595683
    30 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-956-83)
  • ndc11
    4733595688
    100 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-956-88)
  • ndc11
    47335-956-08
  • ndc11
    47335-956-18
  • ndc11
    47335-956-81
  • ndc11
    47335-956-83
  • ndc11
    47335-956-88

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

330 interactions on record for alfuzosin.

Graded by severity as the source publishes them — 47 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check alfuzosin against other medicinesHow interaction checks work

Alfuzosin · interactions on record

330 records

  • 47 severe
  • 182 moderate
  • 3 minor
  • 48 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • PapaverinC04AX38severe

50 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Alfuzosin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All alfuzosin products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Alfuzosin Stada
  • Belgium · Alfuzosine Sandoz, Xatral Retard
  • Cyprus · Alfural, Alfuzosin Aurobindo
  • Czechia · Alfuzosin Viatris
  • Germany · Alfuzosin, Alfuzosin 10 1 A Pharma
  • Denmark · Alfuzosin Orion, Alfuzosin Sandoz
  • Estonia · Alfuzosin Teva, Xatral Sr
  • Spain · Alfuzosina Aurovitas, Alfuzosina Stada
  • Finland · Alfuzosin Hydrochlorid Ratiopharm, Alfuzosin Hydrochloride Orion
  • France · Alfuzosine, Alfuzosine L.P Eg
  • United Kingdom (Northern Ireland) · Alfuzosin Hcl Milpharm, Alfuzosin Hydrochloride Teva Uk
  • Greece · Alcinin, Alfudex
  • Hungary · Alfetim Sr, Alfetim Uno
  • Ireland · Alfu, Xatger
  • Iceland · Alfuzosin Hydrochloride Alvogen
  • Italy · Alfuzosin Ratiopharm, Alfuzosina Aurobindo
  • Lithuania · Xatral Sr
  • Luxembourg · Xatral Uno
  • Latvia · Alfuzosin Teva, Xatral Sr
  • Malta · Zochek
  • Netherlands · Alfuzosine Hcl Aurobindo, Alfuzosine Hcl Cf
  • Poland · Alfabax, Alfurion
  • Portugal · Alfuzosin Teva, Alfuzosina Aurovitas
  • Romania · Xatral Sr
  • Sweden · Alfuzosin Orion, Alfuzosin Rivopharm
  • Slovakia · Alfuzosin Sandoz, Alfuzosin Viatris

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f280d067-b43e-48e6-ac61-bf5263a230a0
GET /v1/drugs/f280d067-b43e-48e6-ac61-bf5263a230a0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "10",
  "substance": "ALFUZOSIN HYDROCHLORIDE",
  "productndc": "47335-956",
  "dosage_form": "TABLET, EXTENDED RELEASE",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA079057",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about alfuzosin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console